Knight Capital Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Knight Capital Group’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$1.25M	Buy	+25,772	New	+$1.27M	0.02%	848

Other funds holding CBST

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Knight Capital Group's CBST Position: Q2 2013 in Review

Knight Capital Group opened a new position in CUBIST PHARMACEUTICALS INC (CBST) in Q2 2013: 25,772 shares worth $1.25M. The stake represents 0.02% of the portfolio and ranks #848 among its holdings.

254 funds tracked by Wall St. Rank hold CBST as of Q2 2013.

Knight Capital Group held 25,772 shares of CUBIST PHARMACEUTICALS INC worth $1.25M as of Q2 2013.
CUBIST PHARMACEUTICALS INC was a new Knight Capital Group position in Q2 2013.
CUBIST PHARMACEUTICALS INC made up 0.02% of Knight Capital Group's portfolio in Q2 2013, its #848 holding.
254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.